(b) The transfer shall be communicated directly between 2 licensed pharmacists.
(c) The transferring pharmacist shall do all of the following:
1. Write the word “VOID” on the face of the invalidated prescription. For electronic prescriptions, information that the prescription has been transferred shall be added to the prescription record.
2. Record on the reverse of the invalidated prescription or in the electronic prescription record all of the following:
a. Name, address and DEA registration number of the pharmacy to which it was transferred.
b. The first and last name of the pharmacist receiving the prescription order.
3. Record the date of the transfer.
4. Record the first and last name of the pharmacist transferring the information.
(d) For paper prescriptions and prescriptions received verbally and reduced to writing by the pharmacist, the pharmacist receiving the transferred prescription information shall write the word “TRANSFER” on the face of the transferred prescription and reduce to writing all information required to be on prescription, including all of the following:
1. Date of issuance of the original prescription order.
2. Original number of refills authorized on the original prescription order.
3. Date of original dispensing.
4. Number of valid refills remaining and the date and location of previous refills.
5. Pharmacy’s name, address, DEA registration number, and prescription number from which the prescription information was transferred.
8. First and last name of the pharmacist making the transfer.
9. Pharmacy’s name, address, DEA registration number, and prescription number from which the prescription was originally filled.
(e) For electronic prescriptions being transferred electronically, the transferring pharmacist shall provide the receiving pharmacist with the original electronic prescription data and all of the following:
1. The date of the original dispensing.
2. The number of refills remaining and the dates and locations of previous refills.
3. The transferring pharmacy’s name, address, DEA registration number, and prescription number for each dispensing.
4. The first and last name of the pharmacist transferring the prescription.
5. The name, address, DEA registration number, and prescription number from the pharmacy that originally filled the prescription, if different.
(4) Use of shared computer system. A shared computer system used for transferring prescription order information shall, in addition to meeting the requirements of s. Phar 7.11 (2) (a), contain a shared real time electronic file database with complete prescription record filled and dispensed. Phar 7.05 Label requirements (1) This section does not apply to institutional pharmacies as defined in s. Phar 7.50 (2). (2) All prescribed drugs or devices shall have a label attached to the container disclosing all of the following:
(a) Identification of the patient by one of the following:
1. Except as provided in subds. 2. to 5., the first and last name of the patient.
2. For an antimicrobial drug dispensed under s. 450.11 (1g), Stats., the first and last name of the patient, if known, or the words, “expedited partner therapy” or the letters “EPT”. 3. For an opioid antagonist when delivered under s. 450.11 (1i), Stats., the first and last name of the person to whom the opioid antagonist is delivered. 4. For an epinephrine auto-injector prescribed under s. 118.2925 (3) or 255.07 (2), Stats., the name of the school, authorized entity, or other person specified under s. 255.07 (3), Stats. 5. If the patient is an animal, the last name of the owner, name of the animal and animal species.
(b) Symptom or purpose for which the drug is being prescribed if the prescription order specifies the symptom or purpose.
(c) Name and strength of the prescribed drug product or device dispensed, unless the prescribing practitioner requests omission of the name and strength of the drug product or device.
(d) The date for which the medication shall not be used after.
(e) Pharmacy name, address and telephone.
(f) Prescriber name.
(g) Date the prescription was filled.
(h) Prescription order number.
(i) Quantity.
(j) Number of refills or quantity remaining.
(k) Written or graphic product descriptions.
(3) A label for prescribed drugs or devices may include the following:
(a) Symptom or purpose for which the drug is being prescribed if requested by the patient.
(b) Both the generic name of the drug product equivalent and the brand name specified in the prescription order may be listed on the label if the brand name is listed on the prescription and the drug product equivalent is dispensed, unless the prescribing practitioner requests that the brand name be omitted from the label.
(c) Any cautions or other provisions.
(4) Sub. (2) does not apply to complimentary samples of drug products or devices dispensed in original packaging by a practitioner to his or her patients.
Phar 7.06 Repackaging for stock. A pharmacy repackaging for stock any non-sterile drugs shall do all of the following:
(1) The repackaging for stock process is conducted under conditions that ensure the integrity of the drug.
(2) Products repackaged for stock shall include a beyond use date that ensures the integrity of the drug.
(3) The repackaged container shall be selected to mitigate adulteration from light, temperature and humidity.
(4) The repackaged for stock drugs are labeled with all the following components:
(a) Drug name, strength and form.
(b) Pharmacy control or manufacturer lot number.
(c) NDC number. If NDC number is unavailable the name of the manufacturer or distributor of the drug product.
(d) Beyond use date.
(5) Records of all repackaging for stock operations are maintained and include all the following:
(a) Name, strength, form, quantity per container, and quantity of containers.
(b) NDC number. If NDC number is unavailable the name of the manufacturer or distributor of the drug product.
(c) Manufacturer lot number.
(d) Original container’s expiration date and the beyond-use date for the new containers.
(e) First and last name of the pharmacist or delegate that repackaged the drug and the first and last name of the pharmacist that verified the accuracy of the repackaging.
(f) Date of repackaging.
Phar 7.07 Final check (1) The final check on the accuracy and correctness of the prescription drug product or device dispensing includes all of the following:
(a) Labeling requirements.
(b) Correct drug product or device.
(c) Completion of the drug utilization review.
(2) For all prescription drug product or device dispensing, the prescription record shall identify the pharmacist responsible for each part of the final check. If sub. (1) (a) or (b) is completed by delegate check delegate under s. Phar 7.14 or automated technology under s. Phar 7.55, the prescription record shall identify the supervising pharmacist. Phar 7.08 Patient consultation. (1) Patient consultation shall include all of the following:
(a) Name and description of the drug.
(b) Form, dose, route of administration and duration for drug therapy.
(c) Intended use of the drug and expected action.
(d) Special directions and precautions for preparation, administration and use by the patient.
(e) Common severe side or adverse effects or interactions and therapeutic contraindications that may be encountered, including their avoidance, and the action required if they occur.
(f) Techniques for self-monitoring drug therapy.
(g) Proper storage and appropriate disposal method of unwanted or unused medication.
(h) Action to be taken in the event of a missed dose.
(2) A pharmacist shall give the patient or patient’s agent consultation relative to the prescription for any new drug product or device which has not been dispensed previously to the patient or any change in the patient’s therapy. Patient consultation shall meet all of the following requirements:
(a) Contain all of the following information, unless in the pharmacist’s professional judgment it serves the best interest of the patient to omit or vary the content of the consultation:
1. Name and description of the drug.
2. Form, dose, route of administration and duration for drug therapy.
3. Intended use of the drug and expected action.
4. Special directions and precautions for preparation, administration and use by the patient.
5. Common severe side or adverse effects or interactions and therapeutic contraindications that may be encountered, including their avoidance, and the action required if they occur.
6. Techniques for self-monitoring drug therapy.
7. Proper storage and appropriate disposal method of unwanted or unused medication.
